Figure 1.
In vitro treatment of human RA-FLS inhibits cell viability and induces apoptosis in a dose- and time-dependent manner. (A) Cells were treated with various concentrations (0, 50, 100, and 200 μM) of silibinin for 12 h, 24 h and 48 h, and then cell viability was determined using the CCK-8 assay as described in the Materials and Methods section. The result is represented as control% compared to the control group. (B) Cells were treated with various concentrations of silibinin (0, 50, 100, and 200 μM) for 48 h and then harvested for apoptosis analysis by staining with Annexin V-FITC and PI. The upper right (UR) quadrant indicates the percentage of late apoptotic cells. (C) Quantitative analysis of the apoptosis rate. Data are presented as the mean ± SD from three independent experiments. *P < 0.05, **P < 0.01 compared to the 0 μM silibinin group.